Monogram Technologies (MGRM) Value Adjusted for Debt and Cash

Official company branding of Monogram Orthopedics Inc. (MGRM)

Monogram Technologies (MGRM) develops robotic systems for joint replacement, targeting the B2B segment of orthopedic centers and expanding its reach through 3D printing of customized prosthetics. Patents on navigation and strict FDA oversight ensure a high barrier to entry. This price chart with the metric demonstrates the valuation of a business whose future stability depends on the adoption rate of the platform across US clinics.

MGRM (Monogram Technologies Inc) Total Company Value history from 07/04/2022 to 10/27/2026

MGRM (Monogram Technologies): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Rate Chart Monogram Technologies Inc.|MGRM - Price Target Chart
- market capitalization data:
Market Value Monogram Orthopedics|MGRM - Total Company Value
- book capitalization data:
Accounting Value per Share Monogram Orthopedics|MGRM - Company Book Value|Market Cap to Net Assets Ratio monogramorthopedics.com|MGRM - Company Total Assets
- debt and liquidity data:
Debt to Capital Monogram Technologies|MGRM - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio monogramorthopedics.com|MGRM - Company Aggregate Debts|Debts to Net Assets Monogram Orthopedics
General company analysis:MGRM (Monogram Technologies Inc.)
Original product of Monogram Technologies Inc.

Enterprise value combines market capitalization with net debt, determining the actual cost of a full business buyout accounting for all liabilities and liquidity. By analyzing the company's total operating valuation, an investor compares the real acquisition price with the scaling potential of mRobotics AI systems in the field of precision orthopedic robotics, assessing the fair value of the technological leadership of Monogram Technologies (MGRM).

Competitor analysis for Monogram Technologies

Intuitive Surgical, Inc. - Full Takeover Company Value|Total Company Value Danaher Corp (DHR)|BDX: Value Adjusted for Debt and Cash|STE (STERIS plc) - Total Company Value|WST (westpharma.com) - Real Price to Acquire Entire Company|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|AtriCure Medical (ATRC) - Real Price to Acquire Entire Company|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value NAGE|Total Company Value ZimVie (ZIMV)|Total Company Value AngioDynamics Inc ANGO|Real Price to Acquire Entire Company Cerus Corp|Value Adjusted for Debt and Cash Teknova Inc TKNO|Enterprise Value STSS (Sharps Tech)|INFU: Company Buyout Price|Total Company Value Utah Medical Products, Inc.|KRMD (KORU Medical) - Business Value|NYXH: Total Company Value|Company Buyout Price Microbot Medical, Inc (MBOT)|Real Price to Acquire Entire Company Pro-Dex, Inc.|Aggregate Business Value ZTEK (zentek.com)|Total Company Value Elutia|MLSS - Value Adjusted for Debt and Cash|NEXGEL, Inc - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)